Glaumetrix – Advanced Ophthalmics

Advanced Ophthalmics

Revolutionizing glaucoma management with real-time data to personalize care as standalone or combination treatment.

Revolutionizing Glaucoma Management

Transforming current standards of care in glaucoma by adding a real-time sensor to ocular implants to monitor Intraocular Pressure (IOP) and provide AI-guided treatment.

Telemetric measurement of intraocular pressure is key to personalized glaucoma management.

Massive and growing patient population with glaucoma

112M projected glaucoma patients globally by 2040
22M estimated to be blind from glaucoma by 2040.
Glaucoma costs the U.S. healthcare system an estimated $2.86 billion annually.
221K+ glaucoma surgeries annually.

Current standard of care is insufficient

IOP is the only modifiable risk factor, yet it is measured only 2–4 times per year.
IOP spikes higher at night when it is not typically measured.
Physicians may misjudge stability due to limited data.
Medication compliance is poor.

Unmet need

Glaucoma patients should be monitored throughout the day.
IOP fluctuates significantly across 24 hours, with dangerous nocturnal peaks when offices are closed.
Lack of continuous monitoring severely handicaps effective treatment.

Tackling the Silent Thief of Sight with a Broad-Based Technological Solution:

Our approach is built on a simple but powerful idea: glaucoma is not a single-stage problem, so it shouldn’t have a single-stage solution. We are developing a three-product portfolio, each designed to meet patients where they are along the continuum of disease, from glaucoma suspects to early, moderate, and severe stages.

Each technology targets a distinct clinical scenario and market:

Standalone use for early detection and routine screening
Integration during cataract surgery for combined treatment and monitoring
Application in glaucoma surgery for advanced disease management

Transformative Smart Sensing Technologies

At Advanced Ophthalmics, we are developing a new generation of smart sensing solutions designed to redefine how glaucoma is monitored and managed. Our technology integrates seamlessly into everyday life, empowering patients and physicians through intelligent, adaptive insights.

Continuous sensing for long-term, reliable measurements
Effortless smartphone integration for easy access and engagement
Instant information sharing that supports collaboration in care
AI-guided intelligence for earlier detection and individualized treatment

Impact of Our Technologies

Treatment Efficacy

Continuous monitoring, combined with AI-guided analysis, allows physicians to evaluate the effectiveness of medications or surgical interventions in real time and make timely adjustments for better outcomes.

Lifestyle Insights

By analyzing daily fluctuations in eye pressure, AI uncovers how stress, sleep, and activity affect IOP. This empowers patients to make informed lifestyle changes that support long-term eye health.

Advancing Research

Our technologies generate an unprecedented stream of continuous IOP data, fueling breakthroughs in ophthalmology research and accelerating the development of future treatments.

Adaptable Technology

With several technologies in the pipeline, our platform is designed for scalability, driving ongoing innovation and enabling expansion across a spectrum of ophthalmic applications.

Company

Advanced Ophthalmics is a medical technology company developing disruptive, proprietary innovations to address unmet needs in glaucoma care. We are introducing a suite of products to provide continuous intraocular pressure (IOP) monitoring.

Our technologies revolutionize glaucoma management by combining real-time pressure readings with AI-powered analysis that delivers predictive insights and personalized care.